Simplex Trading’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-220,200
| Closed | -$42K | – | 8924 |
|
|
2025
Q3 | $42K | Sell |
220,200
-16,500
| -7% | -$19.8K | ﹤0.01% | 6625 |
|
|
2025
Q2 | $402K | Buy |
236,700
+184,700
| +355% | +$312K | ﹤0.01% | 3743 |
|
|
2025
Q1 | $82K | Buy |
52,000
+16,900
| +48% | +$28.6K | ﹤0.01% | 5265 |
|
|
2024
Q4 | $62K | Buy |
+35,100
| New | +$112K | ﹤0.01% | 5639 |
|
|
2024
Q3 | – | Sell |
-4,000
| Closed | -$21K | – | 8758 |
|
|
2024
Q2 | $21K | Buy |
4,000
+200
| +5% | +$1.27K | ﹤0.01% | 6843 |
|
|
2024
Q1 | $32K | Buy |
3,800
+2,800
| +280% | +$24.4K | ﹤0.01% | 6687 |
|
|
2023
Q4 | $6K | Buy |
+1,000
| New | +$4.93K | ﹤0.01% | 7738 |
|
|
2023
Q2 | – | Sell |
-12,800
| Closed | -$38K | – | 9208 |
|
|
2023
Q1 | $38K | Buy |
12,800
+10,100
| +374% | +$29.7K | ﹤0.01% | 6230 |
|
|
2022
Q4 | $6K | Buy |
2,700
+1,400
| +108% | +$4.02K | ﹤0.01% | 7922 |
|
|
2022
Q3 | $2K | Buy |
1,300
+600
| +86% | +$1.58K | ﹤0.01% | 9264 |
|
|
2022
Q2 | $2K | Sell |
700
-1,500
| -68% | -$8.38K | ﹤0.01% | 9332 |
|
|
2022
Q1 | $13K | Buy |
2,200
+1,500
| +214% | +$13.2K | ﹤0.01% | 8654 |
|
|
2021
Q4 | $9K | Buy |
+700
| New | +$7.8K | ﹤0.01% | 9108 |
|
Simplex Trading's EPIX Position: Q4 2025 in Review
Simplex Trading sold out of ESSA Pharma (EPIX) in Q4 2025, closing a stake of 20,381 shares — an estimated $3K sold.
Simplex Trading first reported a position in EPIX in Q3 2022 and held it in 8 quarters. The position peaked at $36K in Q1 2024. 0 funds tracked by Wall St. Rank hold EPIX as of Q4 2025.
- Simplex Trading reported no remaining ESSA Pharma position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 20,381 ESSA Pharma shares in Q4 2025, an estimated $3K.
- Simplex Trading first reported a position in ESSA Pharma in Q3 2022 and held it in 8 quarters.
- Simplex Trading's ESSA Pharma position peaked at $36K in Q1 2024.
- 0 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.